APASL Oncology 2024 in Chiba (2024/9/24-25)で、下記の発表を行いました。教室からは石黒助教が発表しました。
Efficacy of the GFAD Index as a New Indicator for the Early Diagnosis of Non-Viral Hepatocellular Carcinoma
Akiyo Ishiguro, Mitsuaki Nishioka, Toshihiko Kobayashi, Yuki Kunimune, Yutaka Suehiro, Issei Saeki, Taro Takami, Takahiro Yamasaki
The Importance of Assessing Energy Malnutrition in Atezolizumab/Bevacizumab Therapy
Maho Egusa, Issei Saeki, Tsuyoshi Fujioka, Norikazu Tanabe, Takahiro Yamasaki, Taro Takami
A Case of Consciously Selected LEN-TACE for Unresectable HCC Combined with Acquired Thrombocytopenia Purpura
Tsuyoshi Fujioka, Issei Saeki, Maho Egusa, Natsuko Nishiyama, Daiki Kawamoto, Ryo Sasaki, Tatsuro Nishimura, Norikazu Tanabe, Toshihiko Matsumoto, Tsuyoshi Ishikawa, Kaoru Yamamoto, Syota Nono, Yasuharu Ota, Takahiro Yamasaki, Taro Takami
Pretreatment Predictors of Response to Combination Therapy with Atezolizumab/Bevacizumab in Advanced Hepatocellular Carcinoma
Norikazu Tanabe, Issei Saeki, Maho Egusa, Tsuyoshi Fujioka, Takahiro Yamasaki, Taro Takami
Effective Monitoring of Durvlumab plus Tremelimumab Therapy Using Tumor Marker
Issei Saeki, Shigeo Shimose, Tetsu Tomonari, Takanori Ito, Joji Tani, Yasuto Takeuchi, Takeshi Hatanaka, Kyo Sasaki, Sohji Nishina, Motoyuki Otsuka, Hideki Kobara, Takumi Kawaguchi, Takahiro Yamasaki, Taro Takami
